- Home
- BOOT vs TFX Comparison
BOOT vs TFX Comparison
Compare BOOT & TFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BOOT
- TFX
- Stock Information
- Founded
- BOOT 1978
- TFX 1943
- Country
- BOOT United States
- TFX United States
- Employees
- BOOT N/A
- TFX N/A
- Industry
- BOOT Clothing/Shoe/Accessory Stores
- TFX Medical/Dental Instruments
- Sector
- BOOT Consumer Discretionary
- TFX Health Care
- Exchange
- BOOT Nasdaq
- TFX Nasdaq
- Market Cap
- BOOT 5.7B
- TFX 4.8B
- IPO Year
- BOOT 2014
- TFX N/A
- Fundamental
- Price
- BOOT $174.70
- TFX $107.10
- Analyst Decision
- BOOT Strong Buy
- TFX Hold
- Analyst Count
- BOOT 12
- TFX 10
- Target Price
- BOOT $201.73
- TFX $134.88
- AVG Volume (30 Days)
- BOOT 627.5K
- TFX 638.6K
- Earning Date
- BOOT 10-29-2025
- TFX 11-06-2025
- Dividend Yield
- BOOT N/A
- TFX 1.27%
- EPS Growth
- BOOT 36.30
- TFX N/A
- EPS
- BOOT 6.78
- TFX N/A
- Revenue
- BOOT $2,071,382,000.00
- TFX $3,189,988,000.00
- Revenue This Year
- BOOT $18.78
- TFX $10.42
- Revenue Next Year
- BOOT $13.13
- TFX $10.58
- P/E Ratio
- BOOT $25.52
- TFX N/A
- Revenue Growth
- BOOT 17.82
- TFX 5.42
- 52 Week Low
- BOOT $86.17
- TFX $102.58
- 52 Week High
- BOOT $205.31
- TFX $195.47
- Technical
- Relative Strength Index (RSI)
- BOOT 39.71
- TFX 31.16
- Support Level
- BOOT $181.36
- TFX $106.12
- Resistance Level
- BOOT $189.52
- TFX $114.20
- Average True Range (ATR)
- BOOT 8.46
- TFX 4.42
- MACD
- BOOT -2.20
- TFX -1.82
- Stochastic Oscillator
- BOOT 2.53
- TFX 14.82
About BOOT Boot Barn Holdings Inc.
Boot Barn Holdings Inc operates specialty retail stores. The company sells western and work-related footwear, apparel, and accessories in the United States. It is a single operating segment, which includes net sales generated from its retail stores and e-commerce websites.
About TFX Teleflex Incorporated
Teleflex is a Wayne, Pennsylvania-based manufacturer of hospital supplies and medical devices primarily in the bloodstream/vascular and surgical areas. The firm reports results across seven segments: vascular access (24% of 2024 sales), interventional (19%), anesthesia (13%), surgical (15%), interventional urology (11%), original-equipment manufacturing (11%), and other (7%). Geographic exposure for the business is primarily in the US, which accounts for 60% of revenue, with international markets making up the remainder.